Aurora: Investor Presentation

Q1 2020 Key Performance Indicators $44.9M 33% $30.0M Q4 2019 Q1 2020 Consumer Net Revenue $1.14 Q4 2019 25% $0.85 Q1 2020 Cash Cost to Produce/Gram 29,034 43% Q4 2019 41,436 Q1 2020 Kilograms Produced AURORA $25.2M Q4 2019 $5.32M Q4 2019 1% Canadian Medical Net Revenue * Including the impact of $10.6 million in out-of-period adjustments, as reported Q4 2019 SG&A was $72.9 million 7% $83.5M* 3% Q4 2019 $25.5M Q1 2020 Average Net Selling Price/Gram SG&A $5.68M Q1 2020 $81.1M Q1 2020 $4.5M Q4 2019 58% Q4 2019 11% International Net Revenue 84,729 Q4 2019 0% $5.0M Q1 2020 Gross Margin on Cannabis Net Revenue 8% 58% Q1 2020 91,116 Q1 2020 Active Registered Patients 16

View entire presentation